283 related articles for article (PubMed ID: 34389918)
21. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
22. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
[TBL] [Abstract][Full Text] [Related]
23. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
24. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099052
[TBL] [Abstract][Full Text] [Related]
25. NMR-based metabolomics study of canine bladder cancer.
Zhang J; Wei S; Liu L; Nagana Gowda GA; Bonney P; Stewart J; Knapp DW; Raftery D
Biochim Biophys Acta; 2012 Nov; 1822(11):1807-14. PubMed ID: 22967815
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
[TBL] [Abstract][Full Text] [Related]
27. NMR-derived targeted serum metabolic biomarkers appraisal of bladder cancer: A pre- and post-operative evaluation.
Gupta A; Bansal N; Mitash N; Kumar D; Kumar M; Sankhwar SN; Mandhani A; Singh UP
J Pharm Biomed Anal; 2020 May; 183():113134. PubMed ID: 32070930
[TBL] [Abstract][Full Text] [Related]
28. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
29. Abnormalities in metabolic pathways in celiac disease investigated by the metabolic profiling of small intestinal mucosa, blood plasma and urine by NMR spectroscopy.
Upadhyay D; Singh A; Das P; Mehtab J; Dattagupta S; Ahuja V; Makharia GK; Jagannathan NR; Sharma U
NMR Biomed; 2020 Aug; 33(8):e4305. PubMed ID: 32394522
[TBL] [Abstract][Full Text] [Related]
30. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass Spectrometry.
Dittharot K; Jittorntam P; Wilairat P; Sobhonslidsuk A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):741-748. PubMed ID: 29582629
[TBL] [Abstract][Full Text] [Related]
31. Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS.
Eroglu EC; Tunug S; Geckil OF; Gulec UK; Vardar MA; Paydas S
Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):235-248. PubMed ID: 34806450
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.
Jung J; Jung Y; Bang EJ; Cho SI; Jang YJ; Kwak JM; Ryu DH; Park S; Hwang GS
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S736-42. PubMed ID: 25092158
[TBL] [Abstract][Full Text] [Related]
34. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of bladder cancer and prediction of survival by urinary metabolomics.
Jin X; Yun SJ; Jeong P; Kim IY; Kim WJ; Park S
Oncotarget; 2014 Mar; 5(6):1635-45. PubMed ID: 24721970
[TBL] [Abstract][Full Text] [Related]
36. Breast Cancer Metabolomics Using NMR.
Sharma U; Jagannathan NR
Methods Mol Biol; 2019; 2037():195-213. PubMed ID: 31463847
[TBL] [Abstract][Full Text] [Related]
37. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
38. NMR metabolomics study of follicular fluid in women with cancer resorting to fertility preservation.
Castiglione Morelli MA; Iuliano A; Schettini SCA; Petruzzi D; Ferri A; Colucci P; Viggiani L; Cuviello F; Ostuni A
J Assist Reprod Genet; 2018 Nov; 35(11):2063-2070. PubMed ID: 30069850
[TBL] [Abstract][Full Text] [Related]
39. NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients.
Vignoli A; Rodio DM; Bellizzi A; Sobolev AP; Anzivino E; Mischitelli M; Tenori L; Marini F; Priori R; Scrivo R; Valesini G; Francia A; Morreale M; Ciardi MR; Iannetta M; Campanella C; Capitani D; Luchinat C; Pietropaolo V; Mannina L
Anal Bioanal Chem; 2017 Feb; 409(5):1405-1413. PubMed ID: 27900420
[TBL] [Abstract][Full Text] [Related]
40. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]